Evidence map›Paper›PMID 30299406›Full record

ArticleEpidemiology (Cambridge, Mass.)2019

Nonparticipation Selection Bias in the MOBI-Kids Study.

Michelle C Turner, Esther Gracia-Lavedan, Franco Momoli, Chelsea E Langer, Gemma Castaño-Vinyals, Michael Kundi, Milena Maule, Franco Merletti, Siegal Sadetzki, Roel Vermeulen and 14 more

Abstract read
In one paragraph

Article in Epidemiology (Cambridge, Mass.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Michelle C TurnerFrom the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Esther Gracia-LavedanFrom the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Franco MomoliOttawa Hospital Research Institute, Ottawa, Canada.
Chelsea E LangerFrom the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Gemma Castaño-VinyalsFrom the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Michael KundiInstitute of Environmental Health, Medical University of Vienna, Vienna, Austria.
Milena MauleUnit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.
Franco MerlettiUnit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.
Siegal SadetzkiCancer & Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Ramat Gan, Israel.
Roel VermeulenDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Alex AlbertFrom the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Juan AlguacilCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Nuria AragonesCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Francesc BadiaFrom the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Revital BruchimCancer & Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Ramat Gan, Israel.
Gema CarreteroFrom the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Noriko KojimaharaDepartment of Public Health, Tokyo Women's Medical University, Tokyo, Japan.
Brigitte LacourFrench National Registry of Childhood Solid Tumors, CHU, Nancy, France.
Maria Morales-Suarez-VarelaCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Katja RadonInstitute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany.
Thomas RemenFrench National Registry of Childhood Solid Tumors, CHU, Nancy, France.
Tobias WeinmannInstitute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany.
Naohito YamaguchiDepartment of Public Health, Tokyo Women's Medical University, Tokyo, Japan.
Elisabeth CardisFrom the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMOBI-Kids is a 14-country case-control study designed to investigate the potential effects of electromagnetic field exposure from mobile telecommunications devices on brain tumor risk in children and young adults conducted from 2010 to 2016. This work describes differences in cellular telephone use and personal characteristics among interviewed participants and refusers responding to a brief nonrespondent questionnaire. It also assesses the potential impact of nonparticipation selection bias on study findings.

methodsWe compared nonrespondent questionnaires completed by 77 cases and 498 control refusers with responses from 683 interviewed cases and 1501 controls (suspected appendicitis patients) in six countries (France, Germany, Israel, Italy, Japan, and Spain). We derived selection bias factors and estimated inverse probability of selection weights for use in analysis of MOBI-Kids data.

resultsThe prevalence of ever-regular use was somewhat higher among interviewed participants than nonrespondent questionnaire respondents 10-14 years of age (68% vs. 62% controls, 63% vs. 48% cases); in those 20-24 years, the prevalence was ≥97%. Interviewed controls and cases in the 15- to 19- and 20- to 24-year-old age groups were more likely to have a time since start of use of 5+ years. Selection bias factors generally indicated a small underestimation in cellular telephone odds ratios (ORs) ranging from 0.96 to 0.97 for ever-regular use and 0.92 to 0.94 for time since start of use (5+ years), but varied in alternative hypothetical scenarios considered.

conclusionsAlthough limited by small numbers of nonrespondent questionnaire respondents, findings generally indicated a small underestimation in cellular telephone ORs due to selective nonparticipation.

Indexed as

Cell PhoneElectromagnetic FieldsAdolescentBiasBrain NeoplasmsCase-Control StudiesChildFemaleFranceGermanyHumansIsraelItalyJapanMaleOdds Ratio

Identifiers

PMID30299406
PMCPMC6276861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.